<?xml version="1.0" encoding="UTF-8"?>
<p>Other studies followed in subsequent years, aimed at assessing the effects of ingesting 
 <italic>P</italic>. 
 <italic>ostreatus</italic> in the form of fresh, cooked, or dried mushrooms on conditions such as DMT2, dyslipidemia, hypertension, overweight, or obesity. Kajaba et al. [
 <xref rid="B102-ijms-22-00634" ref-type="bibr">102</xref>], for example, showed a significant hypolipidemic effect of 
 <italic>P</italic>. 
 <italic>ostreatus</italic> in their uncontrolled clinical trial of 57 individuals with, primarily, combined types of dyslipidemia, following a daily administration of 10 g of freeze-dried and pulverized mushroom for 6 weeks, and found a significant decrease in TGs, TC, and TC/HDL-C (High-Density Lipoprotein Cholesterol). There was also a decrease in the concentration of conjugated dienes (CDs) in plasma, while glutathione peroxidase (GPX) activity and the concentration of glutathione (GTH) in erythrocytes increased.
</p>
